Third case of Candida dubliniensis endogenous endophthalmitis in North America: Case report and review of the literature

International Ophthalmology

Volumn 34, Issue 4, 2014, Pages 945-950

  Rosenberger, Elizabeth ^a   Youssef, Dima A ^a   Safdar, Sara ^a   Larzo, Cristoforo R ^b   Myers, James ^a  

^a East Tennessee State University   (United States)

^b Southeastern Retina Associates   (United States)

Author keywords

Candida dubliniensis; Endocarditis; Endophthalmitis; Intravenous drug use; Visual acuity

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; FLUCONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CANDIDA DUBLINIENSIS; CANDIDA ENDOPHTHALMITIS; CANDIDEMIA; CASE REPORT; CATARACT; CRACKLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE MOVEMENT DISORDER; FOLLOW UP; FRONTAL LOBE; HEART VENTRICLE FIBRILLATION; HEMIPLEGIA; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; LUNG EXAMINATION; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NEUTROPHIL COUNT; NONHUMAN; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; SPUTUM CULTURE; STAPHYLOCOCCUS INFECTION; SYSTOLIC HEART MURMUR; TACHYCARDIA; TACHYPNEA; THROMBOCYTE COUNT; TONGUE DISEASE; TORSADE DES POINTES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE REPLACEMENT; VENTRICULAR PACEMAKER; VISUAL ACUITY; VITRITIS; CANDIDA; CANDIDIASIS; CLASSIFICATION; COMPLICATION; ENDOPHTHALMITIS; FUNGAL EYE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; SUBSTANCE ABUSE;

ADULT; CANDIDA; CANDIDIASIS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; HUMANS; MALE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84904362268     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-013-9880-x     Document Type: Article

References (28)

1. Odds FC, Bernaerts R (1994) CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32:1923-1929 (Pubitemid 24222272)
2. Riddell J, Comer GM, Kauffman CA (2011) Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 52:648-653
3. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D (2004) Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 137:725-731 (Pubitemid 38446687)
4. Binder MI, Chua J, Kaiser PK et al (2003) Endogenous endophthalmitis. An 18-year review of culture-positive cases at a tertiary care center. Medicine 82:97-105 (Pubitemid 36331641)
5. Essman TF, Flynn HW Jr, Smiddy WE et al (1997) Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 28:185-194
6. Mandell GL (2009) Mandell, Douglas, and Bennett's Principles and practice of infectious diseases, 7th edn. Churchill Livingstone, Philadelphia
7. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC (1995) Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521
8. Svobodova E, Staib P, Losse J, Hennicke F, Barz D, Jozsi M (2012) Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils. J Immunol 189:2502-2511
9. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC (2004) Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4:369-376 (Pubitemid 38156201)
10. Moran GP, Coleman DC, Sullivan DJ (2012) Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int J Microbiol 2012:205921
11. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, Soll DR (1999) Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-D-glucoside as determined with the API 20C Aux and Vitek YBC systems. J Clin Microbiol 37:3804-3808
12. Pincus DH, Coleman DC, Pruitt WR, Padhye AA, Salkin IF, Geimer M, Bassel A, Sullivan DJ, Clarke M, Hearn V (1999) Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 37:3533-3539 (Pubitemid 29491088)
13. Biswas SK, Yokoyama K, Wang L, Nishimura K, Miyaji M (2001) Identification of Candida dubliniensis based on the specific amplification of mitochondrial cytochrome b gene. Nippon Ishinkin Gakkai Zasshi 42:95-98
14. Donnelly SM, Sullivan DJ, Shanley DB, Coleman DC (1999) Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871-1882 (Pubitemid 29396917)
15. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A (2002) PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 19:973-989 (Pubitemid 34918798)
16. Espinosa-Heidmann DG, McMillan BD, Lasala PR, Stanley J, Larzo CR (2012) Candida dubliniensis endophthalmitis: first case in North America. Int Ophthalmol 32:41-45
17. Pelegrin L, Mesquida M, Adan A, Cervera C, Bosch-Mestres J, Esteban-Redondo C, Juiz-Gonzalez P, Llorec V, Miro JM (2011) Candida dubliniensis endophthalmitis in a HIV-infected intravenous drug abuser. Mycoses 54:e856-e858
18. Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH (2010) Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia 169:431-433
19. First Case Report of Candida Dubliniensis endogenous endophthalmitis. R.W. Sedeek, M. Shah1, R. Gentile, C.M. Samson. Ophthalmology, New York Eye and Ear Infirmary, New York, NY; Ophthalmology, New York Medical 365College, New York, NY. http://files.abstractsonline.com/SUPT/163/1808/SessionPDF/156.pdf. Accessed 29 Oct 2012. http://www.nyee.edu/pdf/2008-research-day-roster.pdf
20. Wiwanitkit S, Wiwanitkit V (2013) The first case of Candida dubliniensis endophthalmitis in North America. Int Ophthalmol 33:3
21. Chavan R, Mustafa MZ, Narendran N, Tarin S, Yang Y (2012) A case of Candida albicans endophthalmitis with no predisposing risk factors and a distant source of infection. Case Rep Ophthalmol 3:277-282
22. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC (1997) Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41:617-623 (Pubitemid 27098414)
23. Ruhnke M, Schmidt-Westhausen A, Morschhauser J (2000) Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 46:291-295 (Pubitemid 30639302)
24. Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR (1999) In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 37:870-872 (Pubitemid 29091332)
25. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535
26. Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, Pacheco PA, Lightman S (2012) Factors determining visual outcome in endogenous Candida endophthalmitis. Retina 32:1129-1134
27. Carr MJ, Clarke S, O'Connell F, Sullivan DJ, Coleman DC, O'Connell B (2005) First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol 43:3023-3026 (Pubitemid 40828006)
28. Tran C, Cometta A, Letovanec I, Jaton K, Wenger A, Ruchat P, Jaussi A (2007) Candida dubliniensis in recurrent polymicrobial tricuspid endocarditis. Echocardiography 24:756-759 (Pubitemid 47094231)